Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
Tae Kyoung KimSeung Yeon NohStephanie R WilsonYuko KonoFabio PiscagliaHyun-Jung JangAndrej LyshchikChristoph F DietrichJuergen K WillmannAlexander VezeridisClaude B SirlinPublished in: Clinical and molecular hepatology (2017)
Medical imaging plays an important role in the diagnosis and management of hepatocellular carcinoma (HCC). The Liver Imaging Reporting and Data System (LI-RADS) was initially created to standardize the reporting and data collection of CT and MR imaging for patients at risk for HCC. As contrast-enhanced ultrasound (CEUS) has been widely used in clinical practice, it has recently been added to the LI-RADS. While CEUS LI-RADS shares fundamental concepts with CT/MRI LI-RADS, there are key differences between the modalities reflecting dissimilarities in the underlying methods of image acquisition and types of contrast material. This review introduces a recent update of CEUS LI-RADS and explains the key differences from CT/MRI LI-RADS.
Keyphrases
- contrast enhanced ultrasound
- contrast enhanced
- ion batteries
- magnetic resonance imaging
- computed tomography
- magnetic resonance
- dual energy
- image quality
- high resolution
- diffusion weighted imaging
- solid state
- clinical practice
- end stage renal disease
- healthcare
- big data
- positron emission tomography
- newly diagnosed
- adverse drug
- chronic kidney disease
- deep learning
- machine learning
- mass spectrometry
- fluorescence imaging
- photodynamic therapy